FindTrial
Sign In

TO UNDERSTAND THE EFFECTIVENESS OF HINGUVADI GHRITAPANA AND JATAMAMSADI TAILA NASYA IN THE TREATMENT OF AUTISM IN CHILDREN

EFFICACY OF HINGUVADI GHRITAPANA AND JATAMAMSADI TAILA NASYA IN THE MANAGEMENT OF AUTISM IN CHILDREN- AN OPEN LABELLED CLINICAL TRIAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/12/038875
Enrollment
20
Registered
2021-12-23
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F840- Autistic disorder

Interventions

None listed

Sponsors

Shri BMK Ayurveda Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children satisfying diagnostic criteria

Exclusion criteria

Exclusion criteria: At the time of enrollment, If the child is found to be non inclusive due to underlying health condition or medication will be excluded Children with any acute or chronic, Local or systemic infection will be excluded Children with any congenital malformations Children who are currently under any other medication will be excluded

Design outcomes

Primary

MeasureTime frame
There will be significant effect of Hinguvadi Ghritapana and Jatamamsadi Taila Nasya in the management of autismTimepoint: 7TH,22ND AND 45TH DAYS—

Secondary

MeasureTime frame
There will be significant effect of Hinguvadi Ghritapana and Jatamamsadi Taila Nasya in the management of autismTimepoint: 7TH,22ND AND 45TH DAYS—

Countries

India

Contacts

Public ContactDr Vaishnavi V

KAHER Shri BMK Ayurveda Mahavidyalaya

azizarbar.kaher@kleayurworld.edu.in9844532113

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026